Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Biocoupled drugs

WuXi XDC Cayman announced Thursday that it expects to report its net profit last year jumped more than 80% from 2022, while its adjusted net profit and sales revenue both more than doubled.

FAST NEWS: WuXi XDC’s profit surges on growth in ADC market

The latest: WuXi XDC Cayman Inc. (2268.HK) announced Thursday that it expects to report its net profit last year jumped more than 80% from 2022, while its adjusted net profit and…
February 1, 2024
2268.HK

Recent Articles

WuXi XDC Cayman announced Thursday that it expects to report its net profit last year jumped more than 80% from 2022, while its adjusted net profit and sales revenue both more than doubled.
February 1, 2024

FAST NEWS: WuXi XDC’s profit surges on growth in ADC market

2268.HK

RELATED ARTICLES

  1. WuXi Biologics
    January 16, 2025
    WuXi Biologics sells vaccine plant as new U.S. law looms
    2269.HK
  2. January 15, 2025
    BRIEF: WuXi XDC’s revenue, profit jump in 2024
    2268.HK
  3. February 17, 2025
    Yan Palace flies back to profit growth as revenue sags
    1497.HK
  4. December 27, 2024
    BRIEF: WuXi AppTec sells advanced therapies units in U.K. and U.S.
    2359.HK 603259.SHG
  5. March 21, 2025
    BRIEF: Shanghai Chicmax’s profit surges nearly 70%, growth slows in second half
    2145.HK
  6. January 6, 2025
    Mixue pours up strong growth in China’s overheated bubble tea market
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Premium Content
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2024 Bamboo Works. All rights reserved.